Literature DB >> 19118227

Reversing the tuberculosis upwards trend: a success story in Romania.

C Marica1, C Didilescu, N Galie, D Chiotan, J P Zellweger, G Sotgiu, L D'Ambrosio, R Centis, L Ditiu, G B Migliori.   

Abstract

At present, no published evidence is available on the effectiveness of the DOTS (directly observed treatment, short-course) strategy in reducing the incidence of tuberculosis (TB) within a country in the European "hot spots". The present study aimed to demonstrate the effectiveness of the strategy implementation in reversing the epidemiological TB trend in Romania based on programmatic data analysis. Key programme indicators were analysed from 1998 to 2007, and included DOTS coverage, case-detection rate, treatment success and overall incidence of notified cases. Internationally agreed definitions were used. The key programme indicators began declining and the World Health Assembly targets were reached (79% case-detection of new sputum-smear positive cases and 85.5% success rate in new culture-positive TB cases), 7 yrs after initiation of the DOTS expansion. The success story in Romania suggests that other middle-income, high-incidence countries (i.e. those belonging to the former Soviet Union) might be able to reach the World Health Assembly Targets and curb the burden of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19118227     DOI: 10.1183/09031936.00104308

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  School life expectancy and risk for tuberculosis in Europe.

Authors:  Kazuyo Machiyama; Jan C Semenza; R J Silverwood; Melissa J Palmer; Tek-Ang Lim; Davide Manissero; Andreas Sandgren; George B Ploubidis
Journal:  Int J Public Health       Date:  2015-12-09       Impact factor: 3.380

2.  European union standards for tuberculosis care.

Authors:  G B Migliori; J P Zellweger; I Abubakar; E Ibraim; J A Caminero; G De Vries; L D'Ambrosio; R Centis; G Sotgiu; O Menegale; K Kliiman; T Aksamit; D M Cirillo; M Danilovits; M Dara; K Dheda; A T Dinh-Xuan; H Kluge; C Lange; V Leimane; R Loddenkemper; L P Nicod; M C Raviglione; A Spanevello; V Ø Thomsen; M Villar; M Wanlin; J A Wedzicha; A Zumla; F Blasi; E Huitric; A Sandgren; D Manissero
Journal:  Eur Respir J       Date:  2012-04       Impact factor: 16.671

3.  Learning lessons from the 2009 pandemic: putting infections in their proper place.

Authors:  Angus Nicoll; Marc Sprenger
Journal:  Eur J Epidemiol       Date:  2011-04-13       Impact factor: 8.082

Review 4.  Tuberculosis treatment outcome monitoring in European Union countries: systematic review.

Authors:  Rob van Hest; Csaba Ködmön; Suzanne Verver; Connie G M Erkens; Masja Straetemans; Davide Manissero; Gerard de Vries
Journal:  Eur Respir J       Date:  2012-07-12       Impact factor: 16.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.